The strategy behind the pharmaceutical industry’s flurry of lawsuits challenging drug pricing reform

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Health care CEOs hauled in $4 billion last year as inflation pinched workers, analysis shows

The health care industry didn’t just provide a safe haven for jittery stock investors in 2022, a year defined by inflation and higher interest rates.

August 17, 2023

Feasting for immunity: Study highlights foods that bolster your body’s defenses

Study reviews how certain foods, including fruits, vegetables, spices, and animal products, bolster the immune system. It details the immune-boosting properties of various foods and

November 27, 2023

Florida accounts for 8% of U.S. abortions. With a forthcoming ban, where will patients go?

Abortion access organizations say they are confronting an imminent crisis with Florida’s forthcoming six-week ban on abortion. The state, whose neighboring states also have imposed

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.